Readystate Asset Management LP Sells 180,605 Shares of CryoPort, Inc. $CYRX

Readystate Asset Management LP trimmed its stake in CryoPort, Inc. (NASDAQ:CYRX) by 37.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 304,529 shares of the company’s stock after selling 180,605 shares during the period. Readystate Asset Management LP owned approximately 0.61% of CryoPort worth $2,887,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. AQR Capital Management LLC grew its stake in CryoPort by 285.5% in the 1st quarter. AQR Capital Management LLC now owns 262,596 shares of the company’s stock worth $1,597,000 after buying an additional 194,482 shares in the last quarter. CWM LLC lifted its holdings in shares of CryoPort by 56.2% during the 2nd quarter. CWM LLC now owns 17,697 shares of the company’s stock worth $132,000 after acquiring an additional 6,369 shares during the last quarter. Nisa Investment Advisors LLC increased its stake in CryoPort by 299.9% in the second quarter. Nisa Investment Advisors LLC now owns 3,639 shares of the company’s stock valued at $27,000 after acquiring an additional 2,729 shares during the last quarter. Y Intercept Hong Kong Ltd purchased a new stake in CryoPort during the second quarter valued at about $292,000. Finally, Savant Capital LLC purchased a new stake in CryoPort during the second quarter valued at about $93,000. 92.90% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at CryoPort

In related news, Director Ramkumar Mandalam sold 11,570 shares of the company’s stock in a transaction that occurred on Wednesday, December 10th. The stock was sold at an average price of $9.99, for a total transaction of $115,584.30. Following the completion of the transaction, the director owned 80,758 shares in the company, valued at $806,772.42. This represents a 12.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 10.00% of the company’s stock.

CryoPort Price Performance

CYRX stock opened at $8.47 on Wednesday. The stock has a market capitalization of $424.08 million, a price-to-earnings ratio of 7.24 and a beta of 1.66. The firm’s 50-day moving average price is $9.73 and its two-hundred day moving average price is $9.39. The company has a current ratio of 15.77, a quick ratio of 15.01 and a debt-to-equity ratio of 0.40. CryoPort, Inc. has a 12-month low of $4.58 and a 12-month high of $11.45.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on CYRX shares. Needham & Company LLC increased their price objective on CryoPort from $11.00 to $12.00 and gave the company a “buy” rating in a research report on Wednesday, November 5th. UBS Group upped their target price on CryoPort from $11.00 to $12.50 and gave the stock a “buy” rating in a research note on Wednesday, November 5th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of CryoPort in a research report on Monday, December 29th. Eight investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, CryoPort currently has a consensus rating of “Moderate Buy” and an average target price of $12.83.

CryoPort Company Profile

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.